FDA Investigator Carl A Perez
Carl A Perez has inspections in 2 countries as of 25 Aug 2023. Carl A Perez has collaborated with a combined 624 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alberto A Viciedo,
Anna R Kwilas,
Bo Liang, PhD,
Daniel L Zheng,
Douglas C Kovace,
Douglas C Kovacs,
Eileen A Liu,
Eric J Cunningham,
Erik W Koester,
Frank J Marciniak,
Gregory Price,
Jessica Chery,
Jianyang Wang,
Jie He,
Jogy George,
John P Mistler,
Jonathan G Matrisciano,
Jose M Cayuela,
Karen E D'orazio,
Kinh Q Mac,
Li Li,
Melba T Rivera,
Melba Trivera Clavell,
Melissa A Zuppe,
Michael R Klapal,
Mindy M Chou,
Nikki S Ramirez,
Obinna R Echeozo,
Priscilla M Pastrana,
Rajiv R Srivastava,
Robert G Ruff,
Sherry G Bous,
Sony Mathews,
Thomas J Arista,
Wei Wang, PhD,
Xiuju Lu,
Yvesna C Blaise,
Zakaria I Ganiyu,
Zhaohui Ye
Carl A Perez's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2022 | FDA 483 | Krystal Biotech, Inc. - Form 483, 2022-11-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more